When delivering medicine is time critical

In this episode, we’re looking at the unique approach France has taken to try and get new and innovative treatments to patients faster, and what other national health bodies could learn from this process.

Joining us is an expert in market access and health policy, who has been at the forefront of recent regulatory changes in France and brings with her a wealth of knowledge from a career spanning three decades in pharmaceuticals.

This recording was organised and funded by Johnson & Johnson

June 2024

CP-460651

Hosted on Acast. See acast.com/privacy for more information.